Answers are grounded in this paper and cite their sources.
Background Gastrointestinal (GI) endoscopy is one of the most commonly performed procedures in older adults, who constitute an increasing proportion of the endoscopic population yet face a higher risk of sedation-related cardiorespiratory adverse events, delayed recovery, and postoperative neurocognitive disturbances. Remimazolam, an ultra-short-acting benzodiazepine metabolised by tissue esterases independently of hepatic and renal function, is a candidate sedative of particular interest in this group. However, the extent and gaps of the available evidence specific to sedation with remimazolam in elderly patients undergoing GI endoscopy have not been systematically mapped. Objectives To systematically map the existing evidence on the use of remimazolam for procedural sedation in elderly patients (aged ≥65 years) undergoing GI endoscopy, characterising study design, reported outcomes, comparators, and dosing regimens, and identifying knowledge gaps. Methods This scoping review will be conducted in accordance with the JBI methodology for scoping reviews and reported following the PRISMA extension for Scoping Reviews (PRISMA-ScR). We will search PubMed, Embase, the Cochrane Central Register of Controlled Trials (CENTRAL), Web of Science, and Scopus, together with the Chinese databases CNKI, Wanfang, and VIP (CQVIP), from 1 January 2015 to the search date—a start date that precedes the earliest published clinical reports of remimazolam. Google Scholar will be used as a supplementary source for grey literature and additional records. The search will be further supplemented by trial registries (ClinicalTrials.gov, the WHO International Clinical Trials Registry Platform[ICTRP], and the Chinese Clinical Trial Registry[ChiCTR]), citation chasing, and additional grey literature. Eligibility will be limited to reports published in English or Chinese, reflecting the substantial body of relevant Chinese-language literature. Two reviewers will independently screen records and extract data using a piloted extraction form. Results will be presented in tabular and diagrammatic form alongside a narrative synthesis and an evidence map. Expected results and dissemination This scoping review is expected to map the current extent, range, and nature of evidence on remimazolam for sedation in elderly patients undergoing gastrointestinal endoscopy, will map the volume, designs and outcomes of existing studies and, by visualising this evidence, identify gaps to inform trial design in this high-risk population. The findings will be disseminated through publication in a peer-reviewed journal and presentation at relevant academic conferences.
No takes yet. Share an insight, caveat, or question.
Tao et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: